Summit Therapeutics plc Gains 48.18%

Mon, Aug 22, 2022 at 06:55 PM
Summit Therapeutics plc Gains 48.18%

Summit Therapeutics plc (SMMT:NASDAQ) soared at $1.63, representing a gain of 48.2%. On Mon, Aug 22, 2022, SMMT:NASDAQ hit a New 2-Week High of $1.63. The stock appeared on our News Catalysts scanner on Fri, Aug 19, 2022 at 02:15 PM in the 'MISCELLANEOUS' category. From Mon, Aug 08, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days

About Summit Therapeutics plc (SMMT:NASDAQ)

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.